What is your neoadjuvant chemotherapy of choice in patients with ER+ breast CA who are receiving neoadjuvant therapy with goal to convert to BCS from mastectomy?
Would your decision for anthracycline change if the patient were elderly?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Huntsman Cancer Institute at the University of Utah
Answered on
I have tried to use Dose dense doxorubicin and cyclophosphamide followed by dose dense paclitaxel (AC-T) in most situations in the neoadjuvant setting since lymph node status is not known definitively prior to surgery. There is adjuvant data from the ABC trial for non inferiority of docetaxel and cy...
Join for free or sign in to see the full answer